A recent study on the application of metagenomic next-generation sequencing (mNGS) found that mNGS can achieve early ...

Eligible patients with previously untreated, metastatic squamous non–small-cell lung cancer (NSCLC) were randomly assigned 1:1 to pembrolizumab 200 mg or placebo plus carboplatin and ...

In the Temel et al study, one-third of patients with advanced lung cancer thought their disease was curable at the time of enrollment in the study, and a majority endorsed getting rid of all cancer as ...

Still, the therapies’ modest benefit as a maintenance therapy points to how better treatments are needed for small cell lung ...

Researchers at UC San Diego, led by Professor Trey Ideker (right) are included in a $142 million initiative from ARPA-H with the goal of creating adaptive and personalized cancer ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

AS a marathon runner and someone who’d never smoked, Warren Gray wasn’t worried when he developed what he thought was an ...